抗癌药治疗是肺癌治疗的一大支柱。小细胞肺癌虽已成为治疗的主体,但近年来已经明确了非小细胞肺癌术前、术后化学疗法的有用性,其重要性进一步增大。不过,由于不能满足其治疗成绩,目前肺癌仍然预后不良。其主要原因之一是抗癌药无效,存在着所谓的抗癌药耐药性问题,它分为从一 Anti-cancer drug treatment is a major pillar of lung cancer treatment. Although small cell lung cancer has become the mainstay of treatment, the usefulness of preoperative and postoperative chemotherapy for non-small cell lung cancer has been clarified in recent years and its importance has further increased. However, because of its failure to meet its medical record, lung cancer still has a poor prognosis. One of the main reasons is that anticancer drugs are ineffective and there is a problem of so-called anticancer drug resistance.